香港政府3月24日 (星期三) 宣布即时全面暂停接种由中国复星医药和德国BioNTech合作生产的复必泰疫苗，原因是一个批次的疫苗药瓶封盖包装有瑕疵。

[happy 2016]

香港政府3月24日 (星期三) 宣布即时全面暂停接种由中国复星医药和德国BioNTech合作生产的复必泰疫苗，原因是一个批次的疫苗药瓶封盖包装有瑕疵。

港府称，已与生产商复星医药举行紧急会议，生产商会检视当地厂房及疫苗到港的物流链，在完全解决问题前不会恢复接种。

香港卫生署署长陈汉仪在记者会上表示，至今已为市民接种15万剂复必泰，全部都是现时要停用的第一批次。前线人员曾报告包装上有裂痕、樽盖松脱等情况，已要求代理商向生产商跟进。她强调，前线负责接种人员一旦发现疫苗樽盖松脱，或液体外漏等情况，针剂均会弃置不会使用。

据悉，至今共有两个批次的复必泰到港，分别为第一批次编号为210102，数量58.5万剂疫苗在2月28日到达香港；和第二批次编号210104，78.8万剂3月7日到港。生产商收到港府报告后，今早书面通知港府，暂时看不到有安全问题，但会全面调查，要求港府暂停使用批次210102。陈汉仪表示，第二批次的210104的疫苗暂时仍储存在仓内未使用，同样被生产商要求封存，暂时不能使用。

陈汉仪指出，日前已接种第一剂的市民中，本来最快本星期六可注射第二剂，政府会要求生产商回覆本港现存批次能否使用，否则会要求提供新货。她说，参考临床数据，复必泰第二剂可在19至42日内注射。

统筹疫苗接种计划的公务员事务局局长聂德权则表示，接种中心截至下午1时已使用约1080剂复必泰。另外，目前已解冻的复必泰疫苗有约11000剂，相信这些针剂有相当大可能不能再用。

根据BioNTech资料，复必泰疫苗需要在摄氏-70度超低温储存，生产起计可存放6个月，但一经解冻，只能在摄氏28度雪柜存放5日。

自从港府开始疫苗接种计划以来，已经共有7人在接种后死亡，其中1人是接种复必泰后死亡，另外6人是接种科兴疫苗后丧生。

 

[向问天]

自从港府开始疫苗接种计划以来，已经共有7人在接种后死亡，其中1人是接种复必泰后死亡，另外6人是接种科兴疫苗后丧生。

这两种各自接种的数量是多少？

 

[lindamy]

这两种各种接种的数量是多少？

没太搞明白，这个BioNTech不是和辉瑞合作的疫苗吗？怎么和这个的复星有关？谁是生产厂家？瓶子没有密封好？

8 hr 19 min ago

Hong Kong and Macao suspend BioNTech vaccine rollout due to packaging defect​

From CNN's Joshua Berlinger in Hong Kong

Authorities in Hong Kong and Macao have suspended the rollout of BioNTech's Covid-19 vaccine citing a packaging defect found in their first batch of doses.

Both governments said in statements Wednesday they had received a letter from BioNTech and its Chinese partner, Fosun Pharma, indicating an issue with the seal on individual vials in batch number 21012.

According to government figures, as of Tuesday, 150,200 people in Hong Kong had received their first dose of the BioNTech vaccine, which outside of China is partnered with US pharmaceutical giant Pfizer.

Although both Fosun and BioNTech "have not found any reason to believe that product safety is at risk," the Hong Kong government said it was suspending vaccinations involving batch 21012, and halting plans to administer a second batch pending an investigation.

"These are preventive measures to continuously ensure the safety of the vaccination program," the statement read.

Prior to halting the BioNTech rollout, Hong Kong offered residents a choice of two vaccines, BioNTech, and Chinese-produced Sinovac. Now those who wish to get vaccinated must either wait until the issue with the BioNTech doses is resolved or go with Sinovac.

Hong Kong is expected to receive doses of the AstraZeneca vaccine at a later date.

Vaccine hesitancy: The BioNTech suspension will likely blunt Hong Kong's mass vaccination drive, which is already moving at a slower-than-expected pace.
Hong Kong Chief Executive Carrie Lam said Tuesday that 6% of the population had taken their first shot, which she sad described as "not bad," though admitted the city could "do better."

Though an estimated 252,800 people have so far received their first dose of Sinovac, hesitancy has been an issue, with many citing a lack of public data regarding clinical trials.

Read more:

RELATED

Hong Kong suspends BioNTech vaccine rollout due to packaging defect​

 

[向问天]

Sinovac, hesitancy has been an issue, with many citing a lack of public data regarding clinical trials.

这个不算吗？

Sinovac Announces Phase III Results of Its COVID-19 Vaccine

Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today announced phase III

www.businesswire.com

 

[lindamy]

这个不算吗？

Sinovac Announces Phase III Results of Its COVID-19 Vaccine

Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today announced phase III

www.businesswire.com

我不懂Sinovac和BioNTech是什么关系？

 

[向问天]

我不懂Sinovac和BioNTech是什么关系？

没关系
一个是中国公司，另外一个是德国公司。

 

[lindamy]

没关系
一个是中国公司，另外一个是德国公司。

they had received a letter from BioNTech and its Chinese partner, Fosun Pharma, indicating an issue with the seal on individual vials in batch number 21012.

According to government figures, as of Tuesday, 150,200 people in Hong Kong had received their first dose of the BioNTech vaccine, which outside of China is partnered with US pharmaceutical giant Pfizer.

我也不明白这两个什么关系，现在香港和澳门到底暂停的是谁生产的，难道中国复星在替辉瑞生产BioNTech 疫苗？

 

[向问天]

我也不明白这两个什么关系，现在香港和澳门到底暂停的是谁生产的，难道中国复星在替辉瑞生产BioNTech 疫苗？

中国复星是大中华区辉瑞疫苗的总代理。

 

[向问天]

连瓶盖都封不严实，到底是谁的错？

 

[lindamy]

中国复星是大中华区辉瑞疫苗的总代理。

密封不合格，中国复星这个代理商是负责包装发货？还只是负责商业发行？

如果仅是商业发行，这新闻稿把厂家的密封问题，却连带发行商中国复星太别有用心了。

连瓶盖都封不严实，到底是谁的错？

 

[向问天]

密封不合格，中国复星这个代理商是负责包装发货？还只是负责商业发行？

如果仅是商业发行，这新闻稿把厂家的密封问题，却连带发行商中国复星太别有用心了。

是不是复星公司包装的我不知道，我猜不是。
但是复星换了名称：复必泰。